Dynavax Technologies
DVAX
#4927
Rank
ยฃ1.32 B
Marketcap
ยฃ11.32
Share price
0.03%
Change (1 day)
6.58%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Market cap: ยฃ1.32 Billion

As of February 2026 Dynavax Technologies has a market cap of ยฃ1.32 Billion. This makes Dynavax Technologies the world's 4927th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ1.32 B-0.92%
2025ยฃ1.34 B-1.52%
2024ยฃ1.36 B-3.99%
2023ยฃ1.41 B26.41%
2022ยฃ1.12 B-10.26%
2021ยฃ1.25 B247.56%
2020ยฃ0.35 B-1.67%
2019ยฃ0.36 B-19.26%
2018ยฃ0.45 B-45.95%
2017ยฃ0.83 B579.8%
2016ยฃ0.12 B-80.32%
2015ยฃ0.62 B120.02%
2014ยฃ0.28 B-8.77%
2013ยฃ0.31 B-3.12%
2012ยฃ0.32 B18.99%
2011ยฃ0.27 B13.02%
2010ยฃ0.23 B403.15%
2009ยฃ47.63 M108.52%
2008ยฃ22.84 M-77.67%
2007ยฃ0.10 B-45.05%
2006ยฃ0.18 B222.05%
2005ยฃ57.79 M-41.41%
2004ยฃ98.65 M

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Dynavax Technologies was reported to be:

ยฃ1.32 Billion
by Nasdaq info icon info icon
ยฃ1.32 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
ยฃ109.84 B 8,167.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ134.52 B 10,024.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ19.28 B 1,351.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ128.70 B 9,586.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ201.26 B 15,047.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ210.18 B 15,718.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ76.20 B 5,635.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
ยฃ75 M-94.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ28.57 B 2,050.30%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel